The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)
NCT ID: NCT00599040
Last Updated: 2013-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
113 participants
INTERVENTIONAL
2005-09-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obesity Risk in African American Women is Determined by a Diet-by-phenotype Interaction
NCT03499509
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
NCT03043235
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise
NCT00795860
The Metabolic Effects of Different Weight Loss Diets
NCT00422630
Racial Differences in the Natriuretic Peptide Response to Glucose Challenge
NCT03072602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Weight loss
Weight loss diet focused on the DASH diet
The DASH diet with weight loss
A reduced calorie diet is provided to participants based on the DASH diet.
DASH diet
The DASH diet without weight loss
The DASH diet without weight loss
participants are given a weight maintainenance diet based on the DASH diet
Diary
Dairy Intervention
Dairy diet
participants are given a high dairy, reduced calorie diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The DASH diet with weight loss
A reduced calorie diet is provided to participants based on the DASH diet.
The DASH diet without weight loss
participants are given a weight maintainenance diet based on the DASH diet
Dairy diet
participants are given a high dairy, reduced calorie diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obese (BMI \> or equal to 30 kg/m2)
* Otherwise generally healthy
Exclusion Criteria
* Malignancy or other states where weight loss is contraindicated (pregnancy
* Individuals with high blood pressure on medications.
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamy Ard, MD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamy D Ard, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham Nutrition Sciences Department
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F040719005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.